Evercore Partners Earnings Calls
| Release date | Oct 29, 2025 |
| EPS estimate | $3.01 |
| EPS actual | $3.48 |
| EPS Surprise | 15.61% |
| Revenue estimate | 1.132B |
| Revenue actual | 1.046B |
| Revenue Surprise | -7.57% |
| Release date | Jul 30, 2025 |
| EPS estimate | $1.78 |
| EPS actual | $2.42 |
| EPS Surprise | 35.96% |
| Revenue estimate | 719.606M |
| Revenue actual | 838.04M |
| Revenue Surprise | 16.46% |
| Release date | Apr 30, 2025 |
| EPS estimate | $1.54 |
| EPS actual | $3.49 |
| EPS Surprise | 126.62% |
| Revenue estimate | 598.867M |
| Revenue actual | 699.022M |
| Revenue Surprise | 16.72% |
| Release date | Feb 05, 2025 |
| EPS estimate | $2.90 |
| EPS actual | $3.41 |
| EPS Surprise | 17.59% |
| Revenue estimate | 745.769M |
| Revenue actual | 975.332M |
| Revenue Surprise | 30.78% |
Last 4 Quarters for Evercore Partners
Below you can see how EVR performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 05, 2025 |
| Price on release | $285.06 |
| EPS estimate | $2.90 |
| EPS actual | $3.41 |
| EPS surprise | 17.59% |
| Date | Price |
|---|---|
| Jan 30, 2025 | $289.52 |
| Jan 31, 2025 | $291.27 |
| Feb 03, 2025 | $283.15 |
| Feb 04, 2025 | $282.85 |
| Feb 05, 2025 | $285.06 |
| Feb 06, 2025 | $285.37 |
| Feb 07, 2025 | $275.51 |
| Feb 10, 2025 | $272.19 |
| Feb 11, 2025 | $265.57 |
| 4 days before | -1.54% |
| 4 days after | -6.84% |
| On release day | 0.109% |
| Change in period | -8.27% |
| Release date | Apr 30, 2025 |
| Price on release | $205.29 |
| EPS estimate | $1.54 |
| EPS actual | $3.49 |
| EPS surprise | 126.62% |
| Date | Price |
|---|---|
| Apr 24, 2025 | $198.25 |
| Apr 25, 2025 | $197.58 |
| Apr 28, 2025 | $197.22 |
| Apr 29, 2025 | $199.00 |
| Apr 30, 2025 | $205.29 |
| May 01, 2025 | $206.13 |
| May 02, 2025 | $213.63 |
| May 05, 2025 | $211.87 |
| May 06, 2025 | $205.70 |
| 4 days before | 3.55% |
| 4 days after | 0.200% |
| On release day | 0.409% |
| Change in period | 3.76% |
| Release date | Jul 30, 2025 |
| Price on release | $310.25 |
| EPS estimate | $1.78 |
| EPS actual | $2.42 |
| EPS surprise | 35.96% |
| Date | Price |
|---|---|
| Jul 24, 2025 | $300.52 |
| Jul 25, 2025 | $301.08 |
| Jul 28, 2025 | $302.54 |
| Jul 29, 2025 | $302.55 |
| Jul 30, 2025 | $310.25 |
| Jul 31, 2025 | $301.14 |
| Aug 01, 2025 | $294.01 |
| Aug 04, 2025 | $300.01 |
| Aug 05, 2025 | $298.66 |
| 4 days before | 3.24% |
| 4 days after | -3.74% |
| On release day | -2.94% |
| Change in period | -0.619% |
| Release date | Oct 29, 2025 |
| Price on release | $292.49 |
| EPS estimate | $3.01 |
| EPS actual | $3.48 |
| EPS surprise | 15.61% |
| Date | Price |
|---|---|
| Oct 23, 2025 | $317.72 |
| Oct 24, 2025 | $324.24 |
| Oct 27, 2025 | $330.30 |
| Oct 28, 2025 | $321.75 |
| Oct 29, 2025 | $292.49 |
| Oct 30, 2025 | $291.66 |
| Oct 31, 2025 | $294.56 |
| Nov 03, 2025 | $300.21 |
| Nov 04, 2025 | $297.61 |
| 4 days before | -7.94% |
| 4 days after | 1.75% |
| On release day | -0.284% |
| Change in period | -6.33% |
Evercore Partners Earnings Call Transcript Summary of Q3 2025
Evercore delivered a very strong Q3 2025 driven by broad-based momentum across its advisory, capital markets, private capital and wealth businesses. Key financials: adjusted net revenues of ~$1.0 billion (up 42% y/y), adjusted operating income up 69% y/y and adjusted EPS of $3.48 (up 71% y/y); adjusted operating margin expanded to 21.8%. Advisory remained the largest contributor (record Q3 advisory fees of $884M, up 49% y/y) while non‑M&A lines (PCA, PFG, restructuring, equities, WM) also produced record or near‑record quarters; on a trailing 12‑month basis roughly half of revenues are non‑M&A. Backlog and deal pipelines strengthened throughout Q3 and into October, with larger strategic transactions leading the recovery and midsized activity building. Europe had its best quarter on record and Evercore closed the Robey Warshaw acquisition (early Oct), adding senior talent and expanding white space coverage; firm now has 168 investment banking Senior MDs (≈+50% vs year‑end 2021). Management expects continued market strengthening into year‑end and 2026 but cautions that typical Q4 seasonality may be less pronounced this year due to strong YTD results, earlier market volatility and potential timing effects from the government shutdown. Balance sheet: cash and investment securities > $2.4B; share repurchases continued (≈170k shares in Q3; total returned ~$624M YTD including dividends). Management remains focused on disciplined non‑comp expense control while investing in talent, technology and global expansion; comp ratio has improved but remains elevated vs historical norms due to heavy hiring, and management expects gradual improvement over time rather than a rapid reversion to prior levels.
Sign In
Buy EVR